Opening up about drug pricing decisions is not optional for biopharma anymore. For the sake of credibility, companies should ...

While 2025 was the year of disruption for Trump’s pharma policies, we expect 2026 to be the year of truth: will the US ...

HONG KONG, Jan. 28, 2026 /PRNewswire/ -- (9926.HK) is pleased to share that the international industry media FirstWord Pharma released its list titled "Spotlight On: The Drugs That ...

Anything that helps Americans lose weight, reduces treatment barriers and makes care more affordable should be welcomed. But ...

India's pharmaceutical and biopharmaceutical industry has welcomed the Union Budget 2026, particularly the launch of the ...

As this complexity deepens, a simple truth emerges: classical measurement frameworks cannot keep pace with a system that is no longer linear, nor even merely non-linear, but fundamentally ...

Takeda Pharmaceutical Company Limited ( TAK) Q3 2026 Earnings Call January 29, 2026 5:30 AM EST ...

For much of the past decade, drug shortages in the United States were treated as episodic disruptions. In 2024, that framing ...

As pharma raced to meet climate targets in 2024 to 2025, it proved that scaling medicines no longer has to mean scaling emissions.

SpyGlass Pharma has randomized the first patients in its 2 registrational phase 3 clinical trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System) for the lowering of intraocular pressure (IOP) ...

Affordable medicine and a skilled workforce are the backbone of growth. But with the pharma industry under strain, both are now at risk, threatening Bangladesh’s economic momentum ...

This week's report explores the pharmaceutical industry’s evolution toward resilient, scalable systems that prioritize ...